Sunny Chopra

Title: The Innovative Contributions of Sunny Chopra

Introduction

Sunny Chopra is a notable inventor based in Gurgaon, India. She has made significant strides in the pharmaceutical field, particularly with her innovative work on stable pharmaceutical compositions. Her contributions are vital for the treatment of patients suffering from myelodysplastic syndromes.

Latest Patents

Sunny Chopra holds a patent for a stable pharmaceutical composition of 5-aza-2'-deoxycitidine. This patent describes ready-to-use, non-aqueous pharmaceutical compositions that comprise 5-aza-2'-deoxycitidine and at least one aprotic solvent. The compositions may also include at least one protic solvent. Additionally, the patent outlines processes for preparing these pharmaceutical compositions and their application in treating patients with myelodysplastic syndromes.

Career Highlights

Sunny Chopra is currently employed at Fresenius Kabi Oncology Limited, where she continues to contribute to the field of oncology. Her work is characterized by a commitment to developing effective pharmaceutical solutions that address critical health issues.

Collaborations

Sunny collaborates with talented professionals in her field, including Dhiraj Khattar and Rajesh Khanna. These collaborations enhance her research and development efforts, leading to innovative solutions in oncology.

Conclusion

Sunny Chopra's contributions to pharmaceutical innovation are commendable and impactful. Her patent for a stable pharmaceutical composition demonstrates her dedication to improving patient care in oncology.